Michele Kearney's Nuclear Wire - Major Energy and Environmental News and Commentary affecting the Nuclear Industry. Nuclear Activities
Wednesday, November 15, 2023
Lilly Announces the Receipt of NRC Consent in Connection with its Proposed Acquisition of POINT Biopharma
Lilly Announces the Receipt of NRC Consent in Connection with its Proposed Acquisition of POINT Biopharma: /PRNewswire/ -- Eli Lilly and Company (NYSE: LLY) today announced that the U.S. Nuclear Regulatory Commission ("NRC") has issued its consent for the indirect...
Subscribe to:
Post Comments (Atom)
No comments:
Post a Comment